Samantha A. Barnes

IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies

T. Kaisho, J. Armitage, A. Bosco, 2021, Frontiers in Immunology.

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies

E. de Jong, B. Foley, Samantha A. Barnes, 2021, Frontiers in Immunology.

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia

U. Kees, R. Endersby, S. Fernandez, 2020, Clinical & translational immunology.

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)

B. Foley, Katherine M. Audsley, Hannah V. Newnes, 2020, International journal of molecular sciences.

Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells

M. Fear, B. Foley, J. Waithman, 2022, Burns & trauma.

Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells

S. Fernandez, E. de Jong, B. Foley, 2022, Frontiers in Immunology.

Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes

S. Stone, B. Foley, Ben Wylie, 2020, Frontiers in Immunology.